Semaglutide SM15 15mg*10vials
Semaglutide is a GLP-1 receptor agonist peptide that mimics the body's natural incretin hormone, representing a widely studied metabolic research compound.
The 15mg single-vial specification offers a moderate concentration step up from the standard 10mg. This formulation is well-suited for medium-dose gradient studies, extended metabolic mechanism experiments, and researchers looking to reduce the number of vials needed for longer experimental timelines. The higher content per vial provides greater preparation flexibility for dose escalation protocols.
Through GLP-1 receptor activation, this compound supports research into insulin secretion regulation, glycemic control pathways, appetite-related signaling, and metabolic homeostasis. It serves as a foundational research tool for investigating gut hormone effects on systemic metabolism.
This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a certificate of analysis provided.
10 vials per pack, designed for medium-scale laboratory research and extended experimental studies.